Abstract:Guided by crystal structures of HIV-1 RT/DAPY complex and molecular modeling studies, a series of novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives were rationally designed via structure-based core refining approach, synthesized through the readily accessible synthetic methods and evaluated for their anti-HIV activities in MT-4 cells. Preliminary biological evaluation indicated that most of the compounds exhibited marked inhibitory activity against the wild-type HIV-1 IIIB. Particularly, compound 7n was the most potent inhibitor against wild-type and K103N/Y181C double resistant mutant strain of HIV-1, possessing EC50 values of 0.02 mu M and 7.6 mu M, respectively, which were much better than or similar to nevirapine (NVP, EC50 = 0.15 mu M, 2.9 mu M) and delavirdine (DLV, EC50 = 0.07 mu M, >36 mu M). Besides, some other compounds, 5b, 7c, 7e, 7f, and 7m, were also endowed with favorable anti-HIV-1 potency (EC50 = 0.07, 0.05, 0.05, 0.07, and 0.05 mu M, respectively), which were better than or similar to those of NVP and DLV, suggesting a high potential to further develop this type of bridgehead nitrogen heterocycle as a novel class of NNRTIs with improved antiviral efficacy and resistance profile. The selected compound, 7i, was found moderately inhibitory towards RT (IC50 = 0.39 mu M), which was higher than for ETV (IC50 = 0.56 mu M). Preliminary structure-activity relationships (SARs) and molecular modeling of these new analogues were detailed in this manuscript. (C) 2014 Elsevier Masson SAS. All rights reserved.

Synthesis of bi-/tricyclic azasugars fused thiazinan-4-one and their HIV-RT inhibitory activity.

Synthesis of Tetracyclic Azasugars Fused Benzo[e][1,3]thiazin-4-one by the Tandem Staudinger/aza-Wittig/cyclization and Their HIV-RT Inhibitory Activity

Synthesis of Seven-Membered Iminosugars Fused Thiazolidin-4-one and Benzthiazinan-4-one and Their HIV-RT Inhibitory Activity.

Synthesis and Biological Activity of Bi/Tricyclic Azasugars Fused Thiazolidin-4-One and Thiazinan-4-One by Microwave-Assisted Tandem Staudinger/Aza-Wittig/Cyclization

Synthesis of Pentacyclic Iminosugars with Constrained Butterfly-Like Conformation and Their HIV-RT Inhibitory Activity.

Synthetic bicyclic iminosugar derivatives fused thiazolidin-4-one as new potential HIV-RT inhibitors.

Design, Microwave-Assisted Synthesis and HIV-RT Inhibitory Activity of 2-(2,6-Dihalophenyl)-3-(4,6-dimethyl-5-(un)substituted-pyrimidin-2-yl)thiazolidin-4-ones

Synthesis and Biological Activity of Bi/tricyclic Azasugars Fused Thiazolidin-4-one and Thiazinan-4-one by Microwave-Assisted Tandem Staudinger/aza-Wittig/cyclization.

Synthesis of Kifunensine Thioanalogs and Their Inhibitory Activities Against HIV-RT and Α-Mannosidase

Microwave Assisted Synthesis and Anti-HIV-RT Activity of Diaryl Benzo[1,3]thiazin-4-ones

A Convenient Synthesis of Novel Thiazolidin-4-one-linked Pseudodisaccharides by Tandem Staudinger/aza-Wittig/cyclization and Their Biological Evaluation.

Synthesis and Anti-Hiv Activity of Triazolo-fused 3′,4′-Cyclic and 4′-Spiro Nucleoside Analogues

Synthesis Of Novel Derivatives Of 4-Amino-3-(2-Furyl)-5-Mercapto-1,2,4-Triazole As Potential Hiv-1nnrtis

Synthesis and Anti-Hiv Evaluation of Novel 1,2,4-Triazole Derivatives As Potential Non-Nucleoside Hiv-1 Reverse Transcriptase Inhibitors

Design, Synthesis And Anti-Hiv-Reverse Transcriptase Activity Of Novel Diaryl Thiazolindin-4-One Derivatives Possessing Amide Linkage On N-3 Position

Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.

Fused Heterocycles Bearing Bridgehead Nitrogen As Potent Hiv-1 Nnrtis. Part 2: Discovery of Novel [1,2,4]Triazolo[1,5-A]pyrimidines Using A Structure-Guided Core-Refining Approach

Synthesis and Biological Activity of Novel 5′-Arylamino-nucleosides by Microwave-Assisted One-Pot Tandem Staudinger/aza-Wittig/reduction

Arylazolylthioacetanilide. Part 8☆: Design, Synthesis and Biological Evaluation of Novel 2-(2-(2,4-dichlorophenyl)-2h-1,2,4-triazol-3-ylthio)-n-arylacetamides As Potent HIV-1 Inhibitors

Synthesis and Biological Evaluation of A Series of 2-((1-substituted-1h-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylme Thyl)Pyrimidin-4(3h)-One As Potential Hiv-1 Inhibitors

Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.